recommeded site for you
harry uptodate
Neurology Science
Skin Care and Treatment
Clinical Diagnose
Medical Study
Liver Health Center
Kedokteran Umum
Information
Harry Mulyono

medical information up to date

Monday, January 5, 2009

ARTERIAL EMBOLUS AND THROMBOSIS

ARTERIAL EMBOLUS AND THROMBOSIS - Jeremy Golding, MD
BASICS
DESCRIPTION
• Acute loss of perfusion distal to occlusion of major artery owing to
- Embolus that migrates to point of occlusion or
- Clot intrinsic to point of occlusion (thrombosis)
• Both are true emergencies.
• Following obstruction of artery, soft coagulum forms both proximally and distally in areas of stagnant flow.
• As clot extends, collateral pathways become involved, and process becomes self-propagating.
• Ultimately, venous circulation can become involved.
• Extent of vascular compromise is critical and determines "golden" period of 4-6 hours. After this time, the profound ischemia leads to irreversible cellular death.
• Distribution of emboli
- Femoral artery: 30%
- Iliac artery: 15%
- Aortic bifurcation: 10%
- Popliteal artery: 10%
- Brachial: 10%
- Mesenteric arteries: 5%
- Renal: 5%
- Cerebral (estimated): 15-20%
• System(s) Affected: Cardiovascular; Hematologic/lymphatic/immunologic
GENERAL PREVENTION
• Anticoagulation in atrial arrhythmia
• Reduction of atherosclerosis risk factors
EPIDEMIOLOGY
• 50-100/100,000 hospital admissions
• A leading cause of limb loss in elderly
• Predominant age: Elderly
• Predominant sex: Male > Female
• Rare in children and during pregnancy
RISK FACTORS
Drug abuse
Genetics
Can be associated with inheritable hypercoagulable and premature atherosclerotic syndromes
ETIOLOGY
• Emboli
• Cardiac
- Atrial flutter/fibrillation
- Valve disease
- Myocardial infarction
- Cardiomyopathy
- Cardiac tumors
- Endocarditis
• Aneurysms: Cardiac, aortic, peripheral
• Thrombosis
- Atherosclerotic occlusive disease
- Aortic and peripheral aneurysms, especially popliteal
- Hypercoagulable states
- Venous gangrene
- Drug abuse
- Heparin allergy (heparin-induced thrombocytopenia)
- Vascular bypass
• Trauma
- Blunt
- Penetrating
- Vascular and cardiac interventional procedures
• Venous thrombosis with patent foramen ovale (paradoxical embolus)
ASSOCIATED CONDITIONS
• Acute mesenteric ischemia
• Renal infarction
• Carotid/cerebrovascular accident
• Multiple emboli
• Digital microembolization


DIAGNOSIS
SIGNS AND SYMPTOMS
• To estimate occlusion location
- Symptoms typically start 1 joint below occlusion.
- Palpable pulses absent below occlusion and accentuated above.
• The 5 Ps: If any one is present, frequent re-evaluations indicated. Proximal occlusions lead to more rapid progression of findings. Occlusion at aortic bifurcation can produce bilateral findings.
- Pain: Diffuse in distal area. If persists, crescendo in nature. Predominates as 1st symptom in embolism. Not alleviated by change of position.
- Pulselessness: Mandatory for diagnosis of embolism or thrombosis. Pedal pulses subject to observer error. Always compare to opposite limb.
- Pallor: Skin color pale early, cyanotic later. Check extremity temperature left to right and top to bottom. Look for signs of chronic ischemia: skin atrophy, loss of hair, thick nails.
- Paresthesia: Numbness early with thrombosis. Light touch 1st to be lost. Not reliable in diabetics. Loss of pain and pressure indicate advanced ischemia.
- Paralysis: Motor defect occurs after sensory and indicates profound ischemia.
TESTS
• EKG
• Special tests
• Noninvasive/indirect
- Doppler: Presence or absence of flow
- Ankle/arm index (AAI; aka ankle/brachial index [ABI]) = dorsal pedal/posterior tibial pressure divided by brachial pressure;
- AAI >0.30 favorable (normal >1)
Lab
For preoperative evaluation, elucidation of cause, or documentation of ischemia severity
• Myocardial/muscle isoenzymes
• Coagulation parameters
• Blood pH/bicarbonate
• Urine myoglobin
• Electrolytes
Imaging
Noninvasive/direct: Duplex imaging if time permits
Diagnostic Procedures/Surgery
Arteriography
• Rarely indicated preoperatively in threatened limb
• May help differentiate thrombosis from embolus in nonthreatened limb
• Useful with occluded grafts
DIFFERENTIAL DIAGNOSIS
• Emboli vs. thrombosis
• Emboli
- Myocardial diseases: Myocardial infarction, arrhythmias (e.g., atrial fibrillation), aneurysms
- Pain as 1st symptom
• Thrombosis
- Absence of heart disease: Infarction, arrhythmias
- Chronic vascular history
- Bilateral changes of chronic ischemia
- Numbness rather than pain as 1st symptom
- Vascular procedures: Bypass/interventional
• Other conditions
- Acute aortic dissection (chest or back pain)
- Acute deep vein thrombosis (massive swelling and warm skin)
- Low flow states
TREATMENT
GENERAL MEASURES
• Time is of the essence.
- Unless contraindicated, systemic heparinization to decrease clot propagation and prophylaxis against further emboli
- Resuscitation and stabilization of patient to extent permitted by time
- Triage, based on detailed exam, history, and Doppler examination, determines appropriate therapy.
• Early subcritical stenosis criteria
- Mild ischemic pain
- Normal neurologic exam
- Capillary refill present
- Arterial signals present by Doppler in distal extremity
- Ankle/arm index >0.30
- Treatment
 Heparin (see "Medications")
 Arteriography
- Embolism
 Surgical removal if acceptable operative risk, for example, balloon embolectomy
 Anticoagulation versus intra-arterial thrombolytics if prohibitive risk
- Thrombosis
 Trial of thrombolytics and correction of arterial defect if good risk
 Anticoagulation if poor risk or thrombolytics contraindicated
• Critical stenosis criteria
- Ischemic pain
- Mild neurologic deficit
- Weakness of dorsiflexion
- Minimal sensory loss: Light touch and/or vibratory
- No pulsatile flow by Doppler
- Venous flow present
- Treatment
 Time to intervention is critical
 Heparin (see "Medications")
 Arteriography
 Individualize thrombolysis and/or operative procedure (depending on extent of thrombosis and amenability for surgical removal)
 Thrombolysis to optimize alternatives
 Adjunctive operative therapy
 Intraoperative lytic therapy: Bypass, patch angioplasty
• Late (nonsalvageable) criteria
- Profound sensory loss
- Muscle paralysis
- Absent capillary refill
- Skin marbling
- Muscle rigor
- No arterial or venous signals by Doppler
- Treatment
 Arteriography usually not warranted
 Attempts at reperfusion contraindicated
 Anticoagulation
 Definitive amputation, if possible
MEDICATION (DRUGS)
First Line
• Heparin
- 80-100 U/kg IV loading dose (~5,000-10,000 U)
- Continuous infusion sufficient to double PTT, generally 18 U/kg/h
• Contraindications
- Heparin:
 Allergy
 Bleeding diathesis
 Trauma (e.g., head injury)
 Hematuria/hemoptysis
 Acute aortic dissection
- tPA/Urokinase
 Nonsalvageable ischemia
 Recent MI
 Aneurysm
 Aortic dissection
 Trauma
 Uncontrolled hypertension
 Recent operative procedure
Second Line
Multiple thrombolytics in development
SURGERY
Angioplasty, Thromboembolectomy
FOLLOW-UP
PROGNOSIS
• 90% good outcome with prompt treatment
• Delayed/untreated associated with high mortality and limb loss
• 20-30% hospital mortality associated with causative factors
COMPLICATIONS
• Acidosis
• Myoglobinuria and acute renal failure
• Hyperkalemia
• Recurrent occlusion
• Failure to remove clot/obstruction
• Compartment syndromes/reperfusion syndrome, delayed or acute: Predisposing factors include
- Combined arterial injury
- Profound and prolonged ischemia
- Hypotension
• Clinical findings of compartment syndrome
- Severe pain
- Pain with passive muscle movement
- Hypesthesias of nerves in compartment
- Paralysis of nerves, especially peroneal foot drop
- Tender, tense edema
- Compartment pressure >30-45 mm Hg
• Consequences of unrecognized compartment syndrome
- Acute
 Amputation
 Sepsis
 Myoglobin renal failure
 Shock
 Multiple organ failure
- Delayed
 Ischemic contracture
 Infection
 Causalgia
 Gangrene
• Treatment of compartment syndrome is fasciotomy.
PATIENT MONITORING
Postoperative monitoring
• Anticoagulation
• Establish brisk diuresis.
• Continued resuscitation and diagnosis, including echocardiography and other studies (see "Causes" and "Risk Factors")
• Monitor perfusion stability.
• Treat/eliminate causative factors.
REFERENCES
1. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest.2004 Sep;126(3 Suppl):609S-26S. Available at www.ngc.gov.
2. Townsend. Sabiston Textbook of Surgery, 17th ed. Boston: Saunders, 2004.
3. Brewster DC, Chin AK, Fogarty TJ. Arterial thrombosis. In: Rutherford RB, ed. Vascular Surgery, 3rd ed. Philadelphia: WB Saunders; 1989.
4. Miller DC, Roon AJ, eds. Diagnosis and Management of Peripheral Vascular Diseases. Menlo Park, CA: Addison-Wesley; 1982.
5. Rutherford RB, Flannigan DP, Gupta SK, et al. Suggested standards of reports dealing with lower extremity ischemia. J Vasc Surg. 1986;64:80-94.

No comments:

Post a Comment